Status
Conditions
Treatments
About
The study purpose is to evaluate the safety and feasibility of the CORolla™ TAA in two treatment groups, "CORolla™ Stand-alone group" and " AVR & CORolla™ Add on group".
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Clinical criteria
Echocardiographic criteria
Exclusion criteria
Cardiovascular disease
Non-cardiovascular disease
Miscellaneous conditions
12 participants in 3 patient groups
Loading...
Central trial contact
Lea Lak, M.D.
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal